Thiogenesis Therapeutics, Corp.

Form D Filings

Industry Group
Other
Entity Type
Corporation
CIK
0001877778
Previous Names
Thiogenesis Therapeutics, Corp., Rozdil Capital Corp
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
8/7/2025 Equity $125,450 $125,450 $0 7/30/2025 8/6/2025 D 000106299325013902
12/20/2023 Equity $252,281 $252,281 $0 12/15/2023 12/20/2023 D 000106299323022931
11/25/2022 Equity $218,303 $218,303 $0 11/18/2022 11/25/2022 D 000106299322022769
8/11/2021 Equity, Option to Acquire, Security to be Acquired, Other $252,756 $252,756 $0 7/30/2021 8/11/2021 D 000106299321007309